5Haynes RB, Sackett DL,Taylor W. Compliance in Health care[ M]. Baltimore John Hopkins Press, 1998 : 1,18.
6Knowler WC, Barrett - Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or met- formin[ J]. N Engl J Med,2002,346(6) :393 -403.
7Upchureh SL. Lifestyle or pharmacological interventions prevent or delay type 2 diabetes in people with impaired glucose tolerance [J]. Evid Based Nuts,2007,10(3):78.
8Narayan KM, lmperatore G, Benjamin SM. Targeting people with prediabetes[ J ]. BMJ ,2002,325 (7361 ) :403 - 4.
9Zimmet P, Shaw J, Alberti KG. Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view[ J]. Dia- bet Med,2003,20(9) :693 -702.
10Joshua A, Beckman, Mark A. Creager, Peter Libby. Diabetes and Atherosclerosis: Epidemiology, Pathophysiology and Management [ J]. JAMA ,2002,287:2570 - 2581.
